The Latest Cardiac and Vascular News
Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing […]
Fourth quarter 2021 revenue of $23.0 million contributed to record full year revenue of $81.6 million, 46% growth over the prior year Established over 75 new customer accounts, expanding and diversifying revenue base Substantial cash and investments of $657.7 million at year-end Maintaining 2022 full year revenue guidance of $105-110 […]
The Biome Opportunity Engine™ leverages advanced machine learning to automatically identify and prioritize clinical and financial performance opportunities with the greatest impact on outcomes. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company, is pleased to introduce the Biome Opportunity Engine™. This groundbreaking solution enables cardiovascular service lines, at individual […]
TOLEDO, Ohio & DIEST, Belgium–(BUSINESS WIRE)–NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its nearing acquisition of Medanex Clinic, a Belgium-based European preclinical research organization. Founded in 2010, Medanex focuses on providing exceptional preclinical services to the medical device industry in Europe and across the globe. […]
SHANGHAI, March 28, 2022 /PRNewswire/ — Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently announced that it has received registration approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) for its independently-developed Hyperflex® Balloon Catheter (Hyperflex®) as the company’s first product approved for marketing in Japan. Hyperflex® obtained CE Mark in 2016 […]
EATONTOWN, N.J.–(BUSINESS WIRE)–Tractus Vascular, LLC today announced the first-in-man use of the TractusTM Crossing Support Catheter (TractusTM CSC). The TractusTM CSC represents a highly novel approach to treating vascular disease. Chronic total occlusion (CTO) remains one of the most challenging pathologies encountered by surgeons and interventionalists in performing endovascular interventions. Drs. John H. Rundback […]
The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]
LOS ANGELES, March 29, 2022 /PRNewswire/ — Australian medical technology company, Artrya Limited, creator of the AI-based solution, Artrya Salix, that supports physicians in the diagnosis of coronary artery disease, today announces the formation of the Company’s American subsidiary, Artrya USA, Inc. (Artrya US) with its headquarters in Los Angeles, California. Ted Schwab and Jory Tremblay have been […]
AWANS, Belgium, March 29, 2022 /PRNewswire/ — Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits of PiCSO® (Pressure Controlled Intermittent Coronary Sinus Occlusion) therapy as an adjunct to conventional primary percutaneous coronary intervention (PCI) for patients presenting with inferior ST-Elevation Myocardial Infarction (STEMI). […]
TORRANCE, Calif., March 28, 2022 /PRNewswire/ — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation is proud to announce the latest installation of a Trinias F12 unity edition (floor mounted cutting-edge angiography system) at Cardiovascular Experts Outpatient facility in Harrisburg, Pennsylvania. The system was installed by Shimadzu’s dealer partner, Alpha Imaging (Willoughby, OH) […]
